All-trans-Retinoic Acid as a Frontline Therapy for Acute Promyelocytic Leukemia
Four newly diagnosed patients of acute promyelocytic leukemia (APL) were treated with 45 mg/m2 all-trans-retinoic acid (ATRA) daily. Two patients achieved complete remission (CR) after 32 a